Engineered MSC-Derived Nanovesicles Delivering Cascade-Responsive Self-Assembling Gd-Based Contrast Agents for Enhanced T2-Weighted MRI of Glioblastoma
Analytical Chemistry · 10.11.2026
DOI: 10.1021/acs.analchem.6c04670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 10.11.2026. Verfasst von Chenchen Wang und 10 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
The clinical management of glioblastoma (GBM) remains severely constrained by the blood−brain barrier (BBB), which impedes both diagnostic and therapeutic interventions. Here, we present an innovative bioengineered platform (hMSC-NV-Gd-CBT) based on human mesenchymal stem cell-derived nanovesicles (hMSC-NVs) that are covalently modified with a self-assembling, small-molecule Gd-based contrast agent (N3-Gd-CBT). These nanovesicles retain the inherent BBB-penetrating capacity of their parent cells while offering substantially higher production yields than conventional hMSC-derived exosomes. Furthermore, the incorporation of glutathione/cathepsin B (CTSB) cascade-responsive self-assembling probe N3-Gd-CBT enables tumor-specific aggregation and accumulation of contrast agents, significantly enhancing T2-weighted MRI contrast in GBM. Systematic evaluation at 9.4 T reveals that hMSC-NV-Gd-CBT generates superior MRI contrast for GBM compared with the free N3-Gd-CBT probe, hMSC-NV-Gd-CBT co-treated with a CTSB inhibitor, and commercial Gd-DTPA. This strategy not only provides a novel diagnostic tool for brain tumors and other neurodegenerative diseases but also opens new avenues for developing next-generation T2-weighted MRI contrast agents.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Zitieren
APA
Wang, C., Wang, L., Liu, P., Dong, J., Zhang, G., Xu, Q., Zheng, Y., Dong, L., Bi, Z., Tian, C., & Yuan, Y. (2026). Engineered MSC-Derived Nanovesicles Delivering Cascade-Responsive Self-Assembling Gd-Based Contrast Agents for Enhanced T2-Weighted MRI of Glioblastoma. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c04670
Vancouver
Wang C, Wang L, Liu P, Dong J, Zhang G, Xu Q, et al. Engineered MSC-Derived Nanovesicles Delivering Cascade-Responsive Self-Assembling Gd-Based Contrast Agents for Enhanced T2-Weighted MRI of Glioblastoma. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c04670
BibTeX
@article{Wang2026,
author = {Wang, Chenchen and Wang, Lulu and Liu, Pingping and Dong, Jiajing and Zhang, Guangtao and Xu, Qingfu and Zheng, Yanmin and Dong, Ling and Bi, Zhongsheng and Tian, Changlin and Yuan, Yue},
title = {Engineered MSC-Derived Nanovesicles Delivering Cascade-Responsive Self-Assembling Gd-Based Contrast Agents for Enhanced T2-Weighted MRI of Glioblastoma},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c04670}
}
EUVIMED